NASDAQ:ANGN

Angion Biomedica News Headlines

$15.48
-0.22 (-1.40 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.07
Now: $15.48
$16.19
50-Day Range
$15.01
MA: $18.99
$25.74
52-Week Range
$12.56
Now: $15.48
$26.30
Volume66,281 shs
Average Volume193,714 shs
Market Capitalization$456.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Angion Biomedica (NASDAQ ANGN) News Headlines Today

SourceHeadline
Angion Biomedica (NASDAQ:ANGN)  Shares Down 3.5% Angion Biomedica (NASDAQ:ANGN) Shares Down 3.5%
americanbankingnews.com - March 31 at 3:42 PM
Angion Biomedica (NASDAQ:ANGN) Issues  Earnings ResultsAngion Biomedica (NASDAQ:ANGN) Issues Earnings Results
americanbankingnews.com - March 31 at 10:08 AM
Angion Biomedica (NASDAQ:ANGN) Given "Buy" Rating at OppenheimerAngion Biomedica (NASDAQ:ANGN) Given "Buy" Rating at Oppenheimer
americanbankingnews.com - March 31 at 8:36 AM
Angion Biomedica (NASDAQ:ANGN) Sees Large Volume IncreaseAngion Biomedica (NASDAQ:ANGN) Sees Large Volume Increase
americanbankingnews.com - March 26 at 11:40 AM
Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated PneumoniaAngion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia
markets.businessinsider.com - March 25 at 12:23 AM
Angion Announces Partial Waiver of Certain Lock-up RestrictionsAngion Announces Partial Waiver of Certain Lock-up Restrictions
finance.yahoo.com - March 19 at 9:43 AM
Angion Biomedica Corp.Angion Biomedica Corp.
barrons.com - March 10 at 1:59 PM
Angion to Participate in Upcoming March Investment ConferencesAngion to Participate in Upcoming March Investment Conferences
markets.businessinsider.com - February 24 at 12:25 AM
Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesAngion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 9 at 7:35 PM
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.